<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=Content-Type content="text/html; charset=iso-8859-1"><BASE
href=http://www.saske.net/ head <>
<META content="MSHTML 6.00.2800.1106" name=GENERATOR></HEAD>
<BODY text=black bgColor=white>
<DIV>
<DIV class=OutlookMessageHeader dir=ltr align=left><FONT face=Tahoma
size=2></FONT></DIV><FONT face=Arial color=#0000ff size=2></FONT>From <A
href="http://www.technologyreview.com/articles/wo_appell040904.asp?trk=top">MIT
Technology Review</A>: A self-professed "troublemaker," Aubrey de Grey works to
scrutinize and encourage work in human longevity. De Grey, 40, is a theoretical
biologist and biogerentologist at the University of Cambridge in England. He is
a cofounder of the Methuselah Mouse Prize, "a contest designed to accelerate
progress toward real longevity - enhancing medicine, promote public interest and
involvement in research on healthy life extension, and encourage more such
research." Technology Review spoke to de Grey as he attended a conference on
gene therapy in Santa Barbara, CA. <BR>Q: 5,000 years? That seems pretty
outlandish. A: I get that reaction a lot - my estimate gives people the
conceptual bends. But if you go through the logic step by step, you'll see that
it's virtually inevitable that we will attain that sort of life expectancy in
that sort of timeframe, just so long as two things work out. First, we will have
to develop first-generation rejuvenation therapies by 2050 or sooner... what
remains for me to explain is why the development of first-generation
rejuvenation therapies - which I'll define as ones that can be applied to people
in their 60s and increase their lifespan by at least 30 years - is enough to
give people who are 25 or younger at the time those therapies arrive a lifespan
not limited by aging in any way.</DIV></BODY></HTML>